Home » Roche Raises Illumina Bid to $51, Seeking Faster Deal
Roche Raises Illumina Bid to $51, Seeking Faster Deal
Illumina, the U.S. maker of gene-mapping tools, rose above Roche’s increased hostile takeover bid, indicating investors are betting that an even higher offer will come.
Bloomberg
Bloomberg
Upcoming Events
-
07May
-
14May
-
30May